Preoperative Hemoglobin and Body Mass Index as Predictors of Safe Aspirate Volume in Liposuction Authors: Marco A. Sanchez-Peña, German Quiroga-Moreno, Maria F. Reyes-Ponce, Clotilde Fuentes-Orozco, Rubi C. Estrada-Hernández, Lázaro Cárdenas-Camarena, Giancarlo Talleri-Ornelas, Luis D. Quiñones-Garcia, Gabino Cervantes-Guevara, Enrique Cervantes-Perez, José P. Gómez-Sierra, Alejandro González-Ojeda, Sol Ramirez-Ochoa, Luis O. Suárez-Carreón, Gonzalo Delgado-Hernández, Arath Guerrero-Carrera, José M. Zepeda-Torres Published: 2026 ABSTRACT Background:Liposuction is one of the most frequently performed aesthetic procedures worldwide. Although generally safe, excessive blood loss and postoperative anemia remain potential complications, particularly in large-volume cases. Current safety guidelines rely on fixed aspirate thresholds rather than individualized physiological parameters. This study aimed to develop and validate a mathematical model to predict the maximum safe fat aspirate volume based on preoperative hemoglobin and body mass index.Methods:A prospective observational study was conducted between January and December 2022 at a tertiary hospital in western Mexico. Female patients aged 18 years or older undergoing primary liposuction were included. Pre- and postoperative hemoglobin levels were measured within 24 hours. The predictive model was defined as: Aspirated volume=Preoperative Hb−Postoperative HbConstant where constant was adjusted by body mass index (0.75 for normal weight, 0.70 for overweight, and 0.60 for obese patients). Correlations between predicted and observed hemoglobin decreases and aspirated volumes were analyzed using the Pearson test.Results:A total of 308 female patients (mean age, 32.2 ± 9.1 y) were analyzed. The mean aspirated volume was 5.17 L. Predicted and observed hemoglobin decreases showed a strong correlation (r = 0.864, P < 0.05). Total aspirated volume correlated significantly with both expected (r = 0.951) and observed (r = 0.793) hemoglobin changes (P < 0.05). No transfusions or major complications occurred.Conclusions:This model accurately estimates postoperative hemoglobin changes and defines individualized aspirate limits, offering a simple and reliable tool to enhance perioperative safety in liposuction. Takeaways Question: Can preoperative hemoglobin and body mass index predict patient-specific safe aspirate limits in liposuction? Findings: In 308 female patients, a model based on preoperative hemoglobin and body mass index showed strong correlation between predicted and observed hemoglobin decreases (r = 0.864, P < 0.05). Total aspirated volume correlated with expected (r = 0.951) and observed (r = 0.793) reductions. No major complications occurred. Meaning: This model links permissible blood loss to aspirated fat, providing a quick, reproducible method to estimate safe aspirate limits and improve individualized planning. INTRODUCTION Liposuction is one of the most frequently performed aesthetic surgical procedures worldwide. According to the International Society of Aesthetic Plastic Surgery, more than 2.3 million liposuctions were performed in 2022, with Mexico accounting for a 14.5% increase compared with previous years.1,2 Over recent decades, the procedure has evolved from localized fat removal to comprehensive body contouring, supported by advances in anatomical understanding, infiltration techniques, and suction technology. Despite its high safety profile, perioperative anemia remains a significant concern, particularly in large-volume procedures. Liposuctions involving the removal of 5000 mL or more of total aspirate have been associated with increased intraoperative blood loss and higher risks of fat embolism, hypovolemia, sepsis, and postoperative anemia.3 Current safety recommendations often rely on fixed aspirate thresholds, such as the traditional 5-L limit, rather than patient-specific physiological parameters, limiting their applicability across diverse body types.4,5 Blood loss during liposuction depends on the infiltration technique used. Dry technique (no infiltration): blood loss is up to 20%–45% of aspirate. Dry technique (no infiltration): blood loss is up to 20%–45% of aspirate. Wet technique (200–300 mL infiltration): blood loss up to 30%; Wet technique (200–300 mL infiltration): blood loss up to 30%; Super-wet technique (1:1 infiltration-to-aspirate ratio): produces 1%–2% blood loss; Super-wet technique (1:1 infiltration-to-aspirate ratio): produces 1%–2% blood loss; Tumescent technique (2–3:1 ratio): results in an estimated 1% blood loss.6,7 Tumescent technique (2–3:1 ratio): results in an estimated 1% blood loss.6,7 However, these estimates only account for the hematocrit found within the aspirate. Approximately 98% of total blood loss occurs in the interstitial compartment, representing “concealed” loss that contributes to postoperative hemoglobin decline and potential hemodynamic instability.8 This concealed loss underscores the need for individualized preoperative evaluation and precise estimation of safe aspirate volumes.8,9 Preoperative hemoglobin concentration has been recognized as an independent predictor of transfusion requirement and postoperative morbidity across surgical specialties.10,11 In liposuction, integrating hemoglobin with patient’s body composition could enhance prediction of tolerable blood loss.12 Cantarelli and Godoy13 demonstrated that aspirate volumes exceeding 5% of body weight were associated with clinical signs of hypovolemia, a threshold that correlates with the Advanced Trauma Life Support definition of class II hemorrhage (15%–30% blood loss). Manzaneda et al9 later proposed a predictive model linking permissible blood loss and total aspirate volume, yielding the formula Y = 383.7 + 3.4 × MPBL – 29.1 × age, where MPBL denotes the maximum permissible blood loss. Although pioneering, this model required multiple variables and did not adjust for differences in body composition or body mass index (BMI). Total blood volume (TBV) has traditionally been estimated using the Nadler formula, which correlates weight and height.14 However, this approach tends to overerestimate TBV in overweight and obese individuals because adipose tissue correlates less to vascular volume than lean mass.15 Consequently, as body fat percentage rises, total body water and blood volume per kilogram decline.16 This physiologic relationship implies that for an equivalent aspirate volume, patients with higher BMI experience a lower hemoglobin decrease. Based on this premise, we developed a simplified mathematical model that incorporates preoperative hemoglobin and BMI to estimate the maximum safe aspirate volume. By introducing a constant that adjusts for body composition and total body water, this model aims to predict postoperative hemoglobin decline and define an individualized aspirate limit. We hypothesized that a strong correlation exists between predicted and observed postoperative hemoglobin decreases, allowing this constant-based formula to serve as a reliable, clinically practical tool for safer perioperative planning in liposuction. MATERIALS AND METHODS Study Design and Setting A prospective observational study was conducted between January and December 2022 at a tertiary-level center in western Mexico. All liposuction procedures were performed by board-certified plastic surgeons under standardized surgical and anesthetic protocols. Patient Selection A consecutive nonprobabilistic sampling was used, including all female patients aged 18 years or older who underwent liposuction as a standalone procedure during the study period. This sampling approach was selected to avoid selection bias and ensure inclusion of all eligible cases available in the center during the study timeframe. Inclusion criteria were BMI between 18 and 35 kg/m2, no previous liposuction or body contouring surgery, and normal preoperative coagulation profile. Exclusion criteria included personal or family history of coagulation disorders, anticoagulant or antiplatelet use within 15 days before surgery, combined surgical procedures, and preexisting anemia or chronic hematologic conditions. Variables and Data Collection The following parameters were recorded for each participant: age, height, weight, BMI, liposuction technique, total aspirated volume, preoperative hemoglobin, postoperative hemoglobin, predicted hemoglobin decrease, and real hemoglobin decrease. Peripheral venous blood samples were obtained immediately before surgery and 24 hours postoperatively. Fluid balance was managed by the anesthesiology team, considered for each case to control for dilutional effects. Hemoglobin levels were measured in g/dL via an automated hematology analyzer (Sysmex, Kobe, Japan). Statistical Analysis Data were analyzed using IBM SPSS Statistics version 26.0 (Armonk, NY). Quantitative variables were expressed as mean and SD or median with interquartile range, depending on data distribution. Normality was tested, showing a parametric distribution. The Pearson test correlation was applied to evaluate associations between predicted hemoglobin decrease and real hemoglobin decrease. A P value less than 0.05 was considered statistically significant. Predictive Model To individualize the relationship between hemoglobin decline and aspirated volume, a constant was introduced to represent the effective circulating blood volume reserve per unit of body mass. This constant was derived from the Nadler formula for estimated blood volume, adjusted for body composition to reflect the inverse relationship between adiposity and circulating blood volume.13,14,16,17 (Table 1). Table 1.Constants Based on BMI and Its Approximate Percentage of Body Water and FatBMI Range% Body Fat (Avg Female)% Body WaterApprox. Blood Volume (mL/kg)Proposed Constant<20 (lean)18–2260–6570–750.8020–25.9 (normal)25–2855–6065–700.7526–29.9 (overweight)30–3550–5560–650.70≥30 (obese)35–4545–5055–600.60Constants were derived from established physiological data correlating BMI ranges with approximate body composition parameters and approximate blood volume (percentages of body water and adipose tissue). Constants Based on BMI and Its Approximate Percentage of Body Water and Fat Constants were derived from established physiological data correlating BMI ranges with approximate body composition parameters and approximate blood volume (percentages of body water and adipose tissue). The constant was defined as follows: This parameter derives from the physiological principle that increasing adiposity reduces total body water and, consequently, TBV per kilogram.14 As adipose tissue is relatively avascular, individuals with higher BMI have a lower proportion of circulating blood relative to total mass. Therefore, for an equivalent postoperative hemoglobin level, they can tolerate a greater aspirate volume compared with leaner patients. The “desired hemoglobin” represents the minimum acceptable postoperative hemoglobin threshold selected by the surgeon based on patient comorbidities and perioperative safety considerations. In most healthy patients, this typically ranges between 9 and 10 g/dL. The constant therefore expresses the relationship between the permissible hemoglobin drop and the maximum aspirate volume a patient can tolerate. Because each desired postoperative hemoglobin value corresponds to a different level of acceptable blood loss, the resulting constant appropriately varies. This reflects standard clinical practice, in which hemoglobin safety thresholds are individualized rather than fixed. The model’s validity was evaluated by comparing predicted and observed postoperative hemoglobin reductions. For practical application, constants were stratified by BMI categories to facilitate intraoperative use. By rearranging the equation, the following formula was obtained to estimate the permissible aspirate volume according to the desired postoperative hemoglobin level: For instance: A patient with preoperative Hb = 13 g/dL, BMI = 27 kg/m2 (C = 0.70), and desired Hb = 9 g/dL yields: Aspirated volume = (13 − 9)/0.7 = 5.7 L. Ethical Considerations The study adhered to the ethical principles for research involving human subjects established by the World Medical Association in the Declaration of Helsinki (1989) and complied with national health legislation. This study is enrolled in National Clinical Trials with the following identifier: NCT06453772. RESULTS A total of 308 female patients were included, with a mean age of 32.2 years (SD 9.1). BMI, height, and weight are also shown in Table 2. Table 2.Baseline Demographic and Anthropometric Characteristics of the Study Population.VariableMeanSDRangeAge (y)329.1718–67Weight (kg)66.29.843–103Height (m)1.600.061.46–1.81BMI (UI)25.63.418.6–34.9Data are presented as mean ± SD. Baseline Demographic and Anthropometric Characteristics of the Study Population. Data are presented as mean ± SD. Among all procedures, the super-wet technique was used in 215 patients (69.8%), whereas the wet technique was used in 93 (30.2%). No tumescent or dry techniques were included. The mean aspirated volume, preoperative hemoglobin level, and postoperative hemoglobin level as well as the predicted and real hemoglobin drop are shown in Table 3. The predicted hemoglobin decrease calculated by the proposed model was 4.78 g/dL (SD 0.95), whereas the observed decrease after surgery was 4.02 g/dL (SD 1.01). The correlation between predicted and real hemoglobin levels was strong (r = 0.864, P < 0.05), demonstrating the model’s predictive validity (Table 3). Table 3.Pre- and Postoperative Hemoglobin Values and Aspirated Fat VolumesVariableMeanSDRangeAspirated fat volume (L)5.71.622.0–10Predicted fat aspirate (L)6.61.442.3–11.67Preoperative Hb (g/dL)13.70.9510.4–17Postoperative Hb (g/dL)9.71.028.6–13.9Predicted Hb drop (g/dL)4.70.951.4–8Real Hb drop (g/dL)4.01.011.1–8.4Data are presented as mean ± SD.Hb, hemoglobin. Pre- and Postoperative Hemoglobin Values and Aspirated Fat Volumes Data are presented as mean ± SD. Hb, hemoglobin. A high correlation was found between the total aspirated volume and the predicted hemoglobin drop (r = 0.951) (P < 0.05) and with the observed hemoglobin drop (r = 0.793) (P < 0.05). No significant complications were observed; when present, they were limited to Clavien–Dindo grade I events. No transfusion requirements were reported. DISCUSSION Our model demonstrates a strong correlation between predicted and observed postoperative hemoglobin values, supporting its potential as a practical tool to individualize surgical planning and minimize bleeding-related complications.11,12 Preoperative hemoglobin is a well-established determinant of perioperative outcomes. Numerous studies have shown that patients with lower baseline hemoglobin values are at an increased risk of transfusion, postoperative anemia, and systemic complications such as myocardial ischemia, acute kidney injury, and prolonged recovery.18–20 In aesthetic surgery, these effects may be underestimated because blood loss is frequently concealed within the interstitial compartment rather than measured directly in the aspirate. Recognizing this hidden component is essential to ensure hemodynamic stability and safe outcomes.9 Our findings reinforce the concept that hemoglobin concentration, when adjusted for BMI, can reliably predict postoperative hemoglobin decline. This correlation enables us to rearrange the formula so surgeons can estimate a personalized aspirate volume for each patient, enhancing safety without relying solely on arbitrary volume thresholds such as the conventional 5-L limit. Prior reports have suggested that volumes exceeding this threshold increase complication risk; however, individualized prediction models may allow safe aspiration above traditional limits in properly selected patients.8,21–23 In our study, postoperative hemoglobin was measured within the first 24 hours because the objective of the model is to predict acute hemoglobin shifts and establish intraoperative safe aspirate limits, rather than long-term hematologic stabilization. Most hemoglobin variation resulting from fluid redistribution occurs during the first 6–12 hours after surgery, which makes postoperative day 1 the clinically relevant timeframe for assessing immediate physiological impact. Measuring hemoglobin on postoperative day 7, as performed by Firas et al,24 is appropriate when comparing suction-device differences or evaluating late equilibration; however, it does not align with the practical purpose of defining real-time, intraoperative decision-making thresholds, which is the central aim of the present predictive model. Although BMI is an accessible clinical proxy, it does not distinguish fat from lean mass or total body water. Even though Chow et al demonstrated that the risk has a proportional relationship between BMI and liposuction volume,17 in our study, patients with higher BMI tolerated larger aspirate volumes with fewer complications, suggesting that their absolute blood volume and interstitial reserves buffer the third-space shift and, consequently, the hemodynamic impact of aspirate removal. As shown with our model, allowing more volume of total fat loss as the BMI goes higher while anticipating a safe hemoglobin threshold without hemodynamic risk.13–15 The model’s simplicity is its main strength. It requires only two variables readily available in routine preoperative assessment—hemoglobin and BMI—making it feasible for use in any surgical setting, even those with limited computational resources. Compared with the earlier formula proposed by Cipriani et al, which incorporated multiple variables (permissible blood loss, sex, weight, and age), our model demonstrates greater predictive strength (r = 0.864 versus R2 = 0.49) while requiring fewer input parameters. It also aligns with recent efforts to apply predictive analytics and artificial-intelligence-assisted models to quantify intraoperative blood loss in aesthetic surgery.25 These approaches share the same goal: objective, individualized safety limits rather than fixed volumetric restrictions. Integrating this predictive model into perioperative planning may assist both surgeons and anesthesiologists in anticipating hemodynamic changes and adjusting fluid management accordingly. This study has limitations. It included only female patients undergoing primary liposuction; only wet and super-wet techniques were used; and results may differ in male patients or combined procedures. The model should be validated prospectively in larger, multicenter cohorts and correlated with postoperative outcomes. Future work could incorporate additional physiological parameters or use machine learning algorithms to refine predictive accuracy. CONCLUSIONS The interaction between permissive blood loss and BMI is a strong predictor of postoperative hemoglobin variation and dictates the hemodynamic tolerance to aspirate volume in liposuction. Evidence agrees on the principle that relative, rather than absolute, volume thresholds should define safety. The proposed model provides a quick, reproducible, and reliable method to estimate safe aspirate limits, enhancing individualized surgical planning and patient safety. DISCLOSURE The authors have no financial interest to declare in relation to the content of this article. PATIENT CONSENT STATEMENT All patients provided written informed consent for participation and data use for research purposes.